MTOR and renal cell carcinoma: Moreover, it was observed to be regulated by mechanistic target of rapamycin kinase (mTOR) activation in the context of tuberous sclerosis complex-associated renal cell carcinoma gene alterations identified through whole-exome sequencing screening [13].